Search
for

    Learn

    5 / 801 results

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn Rapamycin

      mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Valproic acid

      an anticonvulsant repurposed for hair loss via histone inhibition

    Research

    5 / 826 results

    Community Join

    5 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  43 upvotes 6 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community The story of RU58841/PSK3841

      in Research/Science 1 year ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.

      community Is regrowth on an androgen receptor blocker possible?

      in Chat  11 upvotes 1 year ago
      RU and Pyri block androgen receptors to prevent hair loss but may also hinder hair regrowth since they prevent testosterone, which can stimulate hair growth, from binding to these receptors. The user is questioning if this understanding is correct.

      community Research about RU58841 /Why it was stopped

      in Research/Science  29 upvotes 5 years ago
      RU58841 showed promise for treating androgenic alopecia but research was halted due to financial and organizational changes. There were no significant safety concerns reported in human trials.